School of Medicine


Showing 11-20 of 22 Results

  • Run Zhang Shi

    Run Zhang Shi

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsClinical chemistry and therapeutic drug monitoring;
    adult and pediatric clinical endocrine testing;
    screening, detection and follow up of multiple myeloma;
    tumor markers;
    clinical utility of tandem mass spectrometry and high resolution mass spectrometry.

  • Hiroyuki Shimada

    Hiroyuki Shimada

    Professor of Pathology

    BioHiroyuki Shimada, MD, PhD, FRCPA (Hon), is Professor of Pathology and of Pediatrics at the Stanford University Medical Center. He was born in Tokyo, Japan, and completed MD (1973) and PhD (1982) at the Yokohama City University School of Medicine, Yokohama, Japan, and also completed his pathology training at the Children's Hospital (now the Nationwide Children’s Hospital) and the Ohio State University, Columbus, Ohio, USA (1988). Before moving to the Stanford University in 2019, he was Professor of Pathology (Clinical Scholar) at the University of Southern California Keck School of Medicine and working at the Children’s Hospital Los Angeles.
    Dr. Shimada was Chair of the International Neuroblastoma Pathology Committee (1999-2017) and the founder of the International Neuroblastoma Pathology Classification (INPC). As Director of the COG (Children’s Oncology Group) Neuroblastoma Pathology Reference Laboratory (since 2001), he has been actively reviewing pathology samples of ~700 neuroblastoma cases per year from United States, Canada, Australia, and New Zealand. Pathology review results according to the INPC have been providing critical information for patient stratification and protocol assignment in the COG international neuroblastoma clinical trials.

  • Richard Sibley

    Richard Sibley

    Professor of Pathology, Emeritus

    Current Research and Scholarly InterestsImmunologic mechanism of rejection in humans and animal, models of organ transplantation; histological definition of clinical pathology studies of various renal disorders.

  • Arend Sidow

    Arend Sidow

    Professor of Pathology and of Genetics
    On Leave from 04/01/2024 To 02/21/2025

    Current Research and Scholarly InterestsWe have a highly collaborative research program in the evolutionary genomics of cancer. We apply well-established principles of phylogenetics to cancer evolution on the basis of whole genome sequencing and functional genomics data of multiple tumor samples from the same patient. Introductions to our work and the concepts we apply are best found in the Newburger et al paper in Genome Research and the Sidow and Spies review in TIGS.

    More information can be found here: http://www.sidowlab.org

  • Oscar Silva

    Oscar Silva

    Clinical Assistant Professor, Pathology

    BioOscar is an academic hematopathologist who completed anatomic and clinical pathology residency and hematopathology fellowship at Stanford in 2020. Prior to Stanford, he received his MD and PhD from UCLA. His interests include immunology, the pathogenesis and diagnosis of lymphomas, and global health.

  • Raymond A. Sobel, M.D.

    Raymond A. Sobel, M.D.

    Professor of Pathology

    Current Research and Scholarly InterestsWe study cellular and molecular mechanisms of immune-mediated injury in CNS tissues that are affected in multiple sclerosis (MS). We study: 1) tissues of mice with EAE using histology and immunohistochemistry, 2) cross-recognition of neurons by antibodies against myelin proteolipid protein epitopes, and a distinct oligodendrogliopathy induced in mice by the non-protein amino acid azetidine (Aze), (which is found in the human diet); Aze-induced abnormalities mimic those in MS patient CNS tissues

  • Henning Stehr

    Henning Stehr

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsBioinformatics & Clinical Cancer Genomics

  • David Steiner

    David Steiner

    Adjunct Clinical Assistant Professor, Pathology

    Current Research and Scholarly InterestsMechanistic and translational studies to better understand the functional and clinical implications of somatic mutations in aging and cancer.